{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-26-001808","form_type":"8-K","ticker":"TXG","cik":"0001770787","company_name":"10x Genomics, Inc.","filed_at":"2026-01-12T23:59:59+00:00","discovered_at":"2026-05-14T18:02:36.123260+00:00","generated_at":"2026-05-16T10:54:52.215287+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"10x Genomics reports preliminary Q4 rev $166M (+1% YoY); FY 2025 rev $642.8M incl. $44.1M settlements","bullets":["Q4 consumables rev $141.7M (+6% YoY); Spatial consumables up 14% YoY to $41.0M.","Q4 instruments rev $15.5M (-36% YoY); Single Cell instruments down 44% YoY.","Full year rev ex-settlements $598.7M (-2% YoY); instruments rev down 39%.","Cash & securities ~$520M at Dec 31, 2025; cumulative instruments: >6,400 Chromium, >1,500 Spatial.","Single Cell consumables reactions sold increased >20% vs prior year."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-26-001808","json":"https://secwatch.observer/filing/0001628280-26-001808.json","markdown":"https://secwatch.observer/filing/0001628280-26-001808.md","text":"https://secwatch.observer/filing/0001628280-26-001808.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1770787/000162828026001808/0001628280-26-001808-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1770787/000162828026001808/txg-20260111.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T10:54:52.215287+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}